
Metabolomic Profiling Reveals Serum Tryptophan as a Potential Therapeutic Target for Systemic Lupus Erythematosus
Introduction Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease that affects multiple systems throughout the body with an adjusted global prevalence of approximately 50–100 cases per 100,000 adults.1 The etiology of SLE remains …